RET and medullary thyroid gland carcinoma: In 1996, Eng et al. revealed the pathogenicity of RET proto-oncogene mutations in MEN II syndrome and found that codon 768 and 804 mutations only occurred in familial MTC (FMTC), while codon 918 mutations were specific to MEN IIB [22].